Baseline PET Radiomics for Non-Invasive Risk Stratification In Hodgkin Lymphoma
Although most patients with Hodgkin lymphoma (HL) are cured with chemotherapy with or without immunotherapy, a subset fails to respond to first-line therapy. Baseline clinical factors alone do not reliably identify nonresponders. Baseline PET radiomic feature...
Poster Program · Radiopharmaceuticals, Theranostics, and Nuclear Medicine